248 related articles for article (PubMed ID: 8867694)
1. Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in benign, atypical and malignant meningiomas.
Lee MC; Kang MW; Yang BS; Park CS; Juhng SW; Jung S; Kim JH; Kim SH; Kang SS; Lee JH
Noshuyo Byori; 1995; 12(2):133-9. PubMed ID: 8867694
[TBL] [Abstract][Full Text] [Related]
2. Assessment of proliferative potential of meningiomas using PCNA LI and AgNOR counts.
Sudha K; Karak AK; Sharma MC; Mathur M; Sarkar C
Indian J Pathol Microbiol; 1998 Jul; 41(3):323-30. PubMed ID: 9805855
[TBL] [Abstract][Full Text] [Related]
3. Influence of preoperative dexamethasone therapy on proliferating cell nuclear antigen (PCNA) expression in comparison to other parameters in meningiomas.
Gottschalk J; Goebel S; Jautzke G; Martin H; Zimmer C; Märzheuser-Brands S; Cervós-Navarro J
Histol Histopathol; 1992 Oct; 7(4):653-61. PubMed ID: 1360848
[TBL] [Abstract][Full Text] [Related]
4. [Ag-NORs, nucleus-nucleolus-associated antigens (Ki67, PCNA, P-105 and p-120): prognostic markers of meningioma recurrence].
Crafa P; Campanini N; Martella EM; Trabattoni G; Tedeschi F
Acta Biomed Ateneo Parmense; 1994; 65(5-6):297-308. PubMed ID: 8592922
[TBL] [Abstract][Full Text] [Related]
5. Recurrence of meningiomas versus proliferating cell nuclear antigen (PCNA) positivity and AgNOR counting.
Demirtaş E; Yilmaz F; Ovül I; Oner K
Acta Neurochir (Wien); 1996; 138(12):1456-63. PubMed ID: 9030354
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningiomas.
Zimmer C; Gottschalk J; Cervos-Navarro J; Martin H; Beil M; Jautzke G
Pathol Res Pract; 1992 Dec; 188(8):951-8. PubMed ID: 1363764
[TBL] [Abstract][Full Text] [Related]
7. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
Kale A; Söylemez F; Ensari A
Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
[TBL] [Abstract][Full Text] [Related]
8. [Ag-NOR in meningiomas. Clinical and morphologic study of 14 cases].
Cerdá-Nicolás M; Pérez-Bacet M; Piquer J; Barcia-Salorio JL
Arch Neurobiol (Madr); 1992; 55(6):251-5. PubMed ID: 1492778
[TBL] [Abstract][Full Text] [Related]
9. PCNA, Ki-67 and hTERT in residual benign meningiomas.
Maes L; Kalala JP; Cornelissen M; De Ridder L
In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
[TBL] [Abstract][Full Text] [Related]
10. [Nucleolar organizer regions in meningiomas with reference to histopathological findings and recurrence].
Hirayama H; Hara A; Niikawa S; Iwai T; Nishimura Y; Ando T; Sakai N; Yamada H; Takada M
No To Shinkei; 1993 Apr; 45(4):355-61. PubMed ID: 8334021
[TBL] [Abstract][Full Text] [Related]
11. Nucleolar organizer regions in meningiomas. Correlation with histopathologic malignancy grading, DNA cytometry and clinical outcome.
Plate KH; Ruschoff J; Mennel HD
Anal Quant Cytol Histol; 1990 Dec; 12(6):429-38. PubMed ID: 2078265
[TBL] [Abstract][Full Text] [Related]
12. Nucleolar organizer regions in meningiomas.
Radhakrishnan VV; Radhakrishnan NS; Rout D; Misna BK
Br J Neurosurg; 1993; 7(4):377-81. PubMed ID: 8216907
[TBL] [Abstract][Full Text] [Related]
13. Tumor proliferative fraction in infiltrating duct carcinoma.
Kesari AL; Chellam VG; Nair PP; Madhavan J; Nair P; Nair MK; Pillai MR
Gen Diagn Pathol; 1997 Dec; 143(4):219-24. PubMed ID: 9489954
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between the prognosis of retinoblastoma and proliferating cell nuclear antigen and argyrophilic protein at nucleolus organizer regions].
Li D; Song X; Gao Y
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):293-6. PubMed ID: 10451965
[TBL] [Abstract][Full Text] [Related]
15. Invasive meningiomas in relation to high proliferating potential.
Suwa T; Kawano N; Kameya T; Ito H; Oka H; Yada K
Noshuyo Byori; 1993; 10(1):63-7. PubMed ID: 7693228
[TBL] [Abstract][Full Text] [Related]
16. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.
Yu CC; Fletcher CD; Newman PL; Goodlad JR; Burton JC; Levison DA
J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532
[TBL] [Abstract][Full Text] [Related]
17. [A comparison of proliferating cell nuclear antigen immunostaining, nucleolar organizer region staining in lung cancer].
Zhao T; Zhang YL; Li CD
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Dec; 16(6):342-4, 374. PubMed ID: 7913415
[TBL] [Abstract][Full Text] [Related]
18. [Argyrophilic nucleolar organizer region proteins (Ag-NORs) in human central nervous tumors].
Sawada T; Oinuma T; Katada H; Saitoh M; Sakurai I
Rinsho Byori; 1992 Nov; 40(11):1179-84. PubMed ID: 1284911
[TBL] [Abstract][Full Text] [Related]
19. Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining.
Ferraraccio F; Accardo M; Giangaspero F; Cuccurullo L
Clin Neuropathol; 2003; 22(4):187-92. PubMed ID: 12908755
[TBL] [Abstract][Full Text] [Related]
20. Computerized determination of proliferating cell nuclear antigen expression in meningiomas. A comparison with non-automated method.
Konstantinidou A; Patsouris E; Kavantzas N; Pavlopoulos PM; Bouropoulou V; Davaris P
Gen Diagn Pathol; 1997 Jun; 142(5-6):311-6. PubMed ID: 9228254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
